Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.

@article{Oleary2013PreformedCI,
  title={Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation.},
  author={Jacqueline G O'leary and Hugo N Kaneku and Linda W. Jennings and Nubia Banuelos and Brian M. Susskind and PaulI. Terasaki and GoranB. G. Klintmalm},
  journal={Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society},
  year={2013},
  volume={19 9},
  pages={
          973-80
        }
}
Preformed donor-specific human leukocyte antigen antibodies (DSAs) are considered a contraindication to the transplantation of most solid organs other than the liver. Conflicting data currently exist on the importance of preformed DSAs in rejection and patient survival after liver transplantation (LT). To evaluate preformed DSAs in LT, we retrospectively analyzed prospectively collected samples from all adult recipients of primary LT without another organ from January 1, 2000 to May 31, 2009… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

Similar Papers

Loading similar papers…